The leader in RNA-based antisense technology, Isis Pharmaceuticals, has had positive stock action the past few years, based not on hype but on business progress. Antisense has been a lagging and difficult technology, but recent …
“A fabulously strong economy, a record stock market, ISIS defeated and a world …
Isis Pharmaceuticals, Inc. (ISIS) was a big mover last session, as the company saw its shares soar nearly 11% on the day. The move came on the back of a licensing deal with Johnson & Johnson worth up to $835 million. This led to far …
Add in all-time stock market highs, record low employment, the decimation of …
Archaeologists are using 3D printers to reconstruct models of fragile artifacts, including some of the antiquities that in recent years have been destroyed by …
ISIS Power is not the only brand to relinquish its name in the wake of the negative association with the militant organization. Last month, Belgian chocolate-maker ISIS changed its name to Libeert after some customers refused to …
Yesterday a Foreign Affairs sub-committee heard that this money is routed into financial markets in Jordan, where it is …
One stock that might be an intriguing choice for investors right now is Isis Pharmaceuticals, Inc. (ISIS). This is because this security in the pharmaceutical space is seeing solid earnings estimate revision activity, and is in great company …
To explain: ISIS is the most powerful fighting force across northern and eastern Syria. Its main Islamist competitors have all been weakened in recent months. The Salafi brigade Ahrar al-Sham has seen its stock plummet after Qatar curtailed …
CNN3y
There's money going out, not just coming in." 3 divisions worth: ISIS's stock of weapons and equipment "When you look at them as a conventional force, they have approximately at least three divisions — if you think of a Western military …